Results 201 to 210 of about 2,879,484 (330)
Objective Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). This study aimed to externally validate a genetic risk score (GRS) and a combined risk score (CRS) for predicting the risk of RA‐associated PF in an independent cohort of patients with early RA.
Mikael Brink +3 more
wiley +1 more source
Role of tumor‑infiltrating lymphocytes and miR‑155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review). [PDF]
Alvares-Vilela MM +4 more
europepmc +1 more source
Cut elimination for a logic with induction and co-induction
Alwen Tiu, Alberto Momigliano
openalex +2 more sources
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner +14 more
wiley +1 more source
Diagnostic performance of circulating microRNA signatures for differentiating tuberculosis disease from tuberculosis infection. [PDF]
Østergaard AA +12 more
europepmc +1 more source
Reconciling Lambek's restriction, cut-elimination, and substitution in\n the presence of exponential modalities [PDF]
Max Kanovich +2 more
openalex +1 more source
Addressing Economic Insecurities Can Improve Patient‐Reported Outcomes in Lupus
Background Economic insecurities, such as food, housing, transportation, and financial challenges, are modifiable risk factors and influence patient‐reported outcomes (PROs) in systemic lupus erythematosus (SLE). We examined: 1) associations between economic insecurities and PROs; 2) the impact of screening and addressing economic insecurities during ...
Jay Patel +8 more
wiley +1 more source
Using Relative Infant Dose to Assess Drug Exposure in Breastfed Infants. [PDF]
Spigset O.
europepmc +1 more source

